| Log in
Other Photo Credit: Reuters

Aurobindo, Intas bid for Teva’s products in Europe

29 August, 2016

Indian drugmakers Aurobindo Pharma and Intas Pharmaceuticals have submitted binding bids to acquire products from Israel’s Teva Pharmaceutical Industries in the UK, Iceland and Ireland.

A report by The Economic Times said Teva is undergoing a range of divestitures to fulfil anti-trust issues ahead of its $40.5 billion acquisition of Allergan’s generics business. 

The Indian firms have submitted binding bids for $1 billion. While Aurobindo is advised by Morgan Stanley, Intas is advised by investment bank Moelis, the report said.  

Intas and Aurobindo did not immediately respond to email queries for comments. 

This would be Aurobindo’s second bid for Teva’s assets. Last month, the Federal Trade Commission of the US said Aurobindo would acquire one product from Teva in the US region within 10 days of Teva and Allergan’s merger.

Teva is divesting a basket of products across the US, the UK and Middle East to pacify regulators.

In a ruling in March 2016, the European Commission, which addresses competition issues for the European Economic Area (EEA), said the two companies would have to divest most of Allergan’s generics business in the UK and Irish regions which would involve marketed products, products in the pipeline and a manufacturing plant in Barnstaple in UK. 

Teva would also have to divest its portfolio of marketed molecules and those in the pipeline in Iceland, the ruling said.

Last month, the US-based Federal Trade Commission said Teva had found 11 buyers for its basket of over 70 products for the US region. The buyers included Indian firms Dr Reddy’s Laboratories, Zydus Cadila, Cipla and Aurobindo Pharma.  

If Aurobindo wins the bid, it would be able to enhance its European presence. In January 2014, Aurobindo acquired the western European business of Actavis. 

In March 2015, Temasek-backed Intas acquired Combino Pharm’s hospital business in Spain and Portugal for an undisclosed sum.  

Like this report? Sign up for our daily newsletter to get our top reports.


Leave Your Comment
Temasek-backed Intas to buy Teva’s operations under Actavis in UK & Ireland for $769 mn

Temasek-backed Intas to buy Teva’s operations under Actavis in UK & Ireland for $769 mn

TEAM VCC 1 year ago
World’s largest generic drugmaker Teva Pharmaceutical Industries Ltd said on...
Aurobindo Pharma to buy select Teva assets in France

Aurobindo Pharma to buy select Teva assets in France

Ranjani R 12 months ago
Drugmaker Aurobindo Pharma Ltd said on Friday its French unit Arrow Generiques...
Aurobindo Pharma ends big-ticket bid for Mallinckrodt’s generics biz

Aurobindo Pharma ends big-ticket bid for Mallinckrodt’s generics biz

Ranjani R 4 weeks ago
Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the...
No Comments

Aurobindo, Intas bid for Teva’s products in Europe

Powered by WordPress.com VIP